PMC9756388_01
Rippling Patient (RIP) Clinical, Radiologic Features and Deltoid Muscle Biopsy vs Control (CT). Rippling (A.a) Voluntary contraction and active stretching induced rippling phenomenon, which traversed the pectoralis major and deltoid muscles in a wave-like manner. (A.b) Quick and firm percussion of biceps muscle induced muscle mounding (see black arrow). (A.c) Whole-body fluorodeoxyglucose-PET showed a hypermetabolic mediastinal left paracardiac tumor (white arrow) in contact with the lower part of the thymus. (B) Hematoxylin-phloxine-saffron (HPS) staining and immunohistochemistry analyses. (B.a) HPS analysis revealed peri- and endomysial inflammatory infiltrates in the Rippling (RIP) muscle patient. (B.b) Increased expression of peri- and intrafascicular HLA-I in the RIP muscle patient. (B.c) Upregulated expression of peri- and intrafascicular HLA-DR in the RIP muscle patient. (B.d) Increased expression of peri- and intrafascicular CD56 in the RIP muscle patient. (B.e) Caveolin-3 expression in control (CT) muscle. (B.f) Caveolin-3 expression in the RIP muscle patient. Note the strong decrease of Caveolin-3 staining in RIP patient muscle. (B.g) Dysferlin expression in control (CT) muscle. (B.h) Dysferlin expression in RIP patient muscle. Note the strong decrease of staining and distribution perturbation of dysferlin in RIP patient muscle. Magnification x100.
NXI-2022-200075f1.jpg
PMC9756388_01_NXI-2022-200075f1.jpg
F1
A 40-year-old man presented in February 2018 with myalgias and rippling waves of muscle contraction in the pectoralis major and deltoid muscles (Figure 1A; Videos 1 and 2). Whole-body fluorodeoxyglucose-PET showed a hypermetabolic mediastinal left paracardiac tumor in contact with the lower part of the thymus (Figure 1A3). Hematoxylin-phloxine-saffron staining performed on the patient's deltoid muscle biopsy revealed rare perifascicular and endomysial necrotic fibers associated with few pericapillary perimysial and endomysial inflammatory infiltrates (Figure 1B1). CD56-regenerating fibers (Figure 1B2-4). Complementary IHC on frozen muscle sections did not reveal any positive signal for C3, C1q, IgG, -A, and -M, and free light chain kappa and lambda. Of interest, a significative decreased sarcolemmal expression of Caveolin-3 was observed in a mosaic-like pattern associated with disturbed localization of its interacting partner dysferlin (Figure 1B5-8). We failed to detect MURC/Cavin-4 signal in the section through this approach, whereas a strong sarcolemmal signal was concomitantly observed in control healthy individual muscle tissue (eFigure 1A, links.lww.com/NXI/A786). Western blotting investigations performed on the non-iRMD B2 thymoma sample compared with the iRMD B2 thymoma and using the commercial anti-MURC/Cavin-4 confirmed the absence of the 55-kDa MURC/Cavin-4 band in both thymomas (eFigure 1, links.lww.com/NXI/A786). However, a faint MURC/Cavin-4 immunoreactive band around 43 kDa (see red arrow) was specifically detected in both iRMD thymoma and MT extracts but absent from the non-iRMD thymoma sample (eFigure 1B, links.lww.com/NXI/A786).
Electron Microscopy Analyses of Control (CT) and Rippling Patient Skeletal Muscles. CT individual and RIP-thymoma associated rippling patient. Note the presence of caveolae structures in CT (white arrows), which are mainly absent from the RIP patient at the expense of vesicular and tubular structures that accumulate beneath the sarcolemma (white arrowheads and black arrows, respectively). Scale bars 100 and 200 nm, respectively.
NXI-2022-200075f2.jpg
PMC9756388_01_NXI-2022-200075f2.jpg
F2
CD56-regenerating fibers (Figure 1B2-4). Complementary IHC on frozen muscle sections did not reveal any positive signal for C3, C1q, IgG, -A, and -M, and free light chain kappa and lambda. Of interest, a significative decreased sarcolemmal expression of Caveolin-3 was observed in a mosaic-like pattern associated with disturbed localization of its interacting partner dysferlin (Figure 1B5-8). Electron microscopy (EM) approaches revealed as well a reduction of caveolae formation at the sarcolemma level at the expense of an accumulation of vesicular and tubular structures beneath the sarcolemma (Figure 2) as commonly found in inherited caveolinopathies.
iRMD Associated With Thymoma and MURC/Cavin-4 Autoantibodies. (A) Representative WB of myoblast (MB; lane 1) and myotube (MT; lane 2) protein extracts from the immortalized Y711i myoblast cell line or HEK293T cells (lane 3) and probed with anti-Myosin Heavy Chain (MHC) (marker of differentiated MT), patient serum (PS), healthy control serum (HCS) as negative control, patient serum after tumor ablation and immunotherapy (TPS for treated patient serum) and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody as loading control. (B) Representative immunofluorescence of Y711i MT probed with HCS, PS, or TPS (red signal). Note the presence of a strong signal distributed near the sarcolemma when PS was used as a primary antibody (see white arrows). A drastic signal decrease was observed when MT extracts were probed with TPS. No specific signal was observed in MT when probed with HCS. The scale bar is 20 mum. (C) WB validation of the 55 kDa as MURC/cavin-4 immunoreactive band. WB on untransfected HEK293T cells (NT) or transfected with human Flag-tagged Cavin-1, -2, -3, or -4 expressing constructs and probed with the anti-Flag antibody, PS, commercial anti-MURC/Cavin-4 and anti-Cavin-1 antibodies, or GAPDH antibodies as loading control. Note the specific detection of MURC/Cavin-4 by PS. (D) Representative immunofluorescence images of MT probed with the commercial anti-MURC/Cavin-4 antibody. Note the presence of a perfect yellow merge colocalization signal between commercial anti-MURC/Cavin-4 and PS. The scale bar is 10 mum. (E) IHC of control individual (CT) and rippling patient (RIP) skeletal muscle sections probed with the commercial anti-MURC/Cavin-4. Note the decrease of MURC/Cavin-4 expression in a mosaic-like pattern in the thymoma rippling affected patient (see black arrows; x20 magnification).
NXI-2022-200075f3.jpg
PMC9756388_01_NXI-2022-200075f3.jpg
F3
CD56-regenerating fibers (Figure 1B2-4). Complementary IHC on frozen muscle sections did not reveal any positive signal for C3, C1q, IgG, -A, and -M, and free light chain kappa and lambda. Of interest, a significative decreased sarcolemmal expression of Caveolin-3 was observed in a mosaic-like pattern associated with disturbed localization of its interacting partner dysferlin (Figure 1B5-8). A major 55-kDa immunoreactive band was detected with PS in MT extract (Figure 3A). Conversely, when probed with the posttreatment patient serum, a drastic signal decrease of the 55-kDa band was observed (Figure 3A), thus suggesting strong autoantibody titer reduction after tumor resection and immunotherapy. No signal was observed with healthy control serum (Figure 3, A and B). These data were confirmed by immunofluorescence microscopy (Figure 3B). We validated PS specificity for MURC/Cavin-4 by WB on HEK293T cells expressing Flag-tagged Cavin-1-4 (Figure 3C) and immunofluorescence colabeling in human MT using PS and commercial anti-MURC/Cavin-4 (Figure 3D). IHC experiments performed on patient muscle biopsy using commercial anti-MURC/Cavin-4 antibody revealed a decrease of subsarcolemmal MURC/Cavin-4 staining in a mosaic-like pattern (Figure 3E), thus suggesting that MURC/Cavin-4 autoantibodies may induce antibody-mediated protein depletion.